Nisa Investment Advisors LLC Increases Stock Holdings in The Chemours Company (NYSE:CC)

Nisa Investment Advisors LLC lifted its position in The Chemours Company (NYSE:CCFree Report) by 124.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,187 shares of the specialty chemicals company’s stock after purchasing an additional 11,192 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Chemours were worth $273,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. FNY Investment Advisers LLC acquired a new stake in shares of Chemours during the first quarter worth about $27,000. UMB Bank n.a. lifted its holdings in shares of Chemours by 73.9% during the first quarter. UMB Bank n.a. now owns 2,231 shares of the specialty chemicals company’s stock worth $30,000 after purchasing an additional 948 shares during the period. Farther Finance Advisors LLC lifted its holdings in shares of Chemours by 170.7% during the first quarter. Farther Finance Advisors LLC now owns 2,290 shares of the specialty chemicals company’s stock worth $30,000 after purchasing an additional 1,444 shares during the period. Quadrant Capital Group LLC lifted its holdings in Chemours by 100.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 1,119 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Chemours in the fourth quarter valued at $48,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Chemours Stock Performance

Shares of CC opened at $13.25 on Thursday. The Chemours Company has a 52-week low of $9.13 and a 52-week high of $25.38. The company has a quick ratio of 0.83, a current ratio of 1.75 and a debt-to-equity ratio of 7.01. The firm has a market cap of $1.98 billion, a price-to-earnings ratio of 66.27 and a beta of 1.65. The business’s 50 day moving average is $11.48 and its two-hundred day moving average is $13.88.

Chemours (NYSE:CCGet Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The firm had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.36 billion. Chemours had a net margin of 0.54% and a return on equity of 23.82%. Chemours’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 earnings per share. Analysts forecast that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, June 16th. Stockholders of record on Monday, May 19th were issued a dividend of $0.0875 per share. This represents a dividend yield of 3.17%. The ex-dividend date was Friday, May 16th. Chemours’s dividend payout ratio is 175.00%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Truist Financial dropped their price target on Chemours from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, April 14th. Mizuho lifted their price target on Chemours from $13.00 to $16.00 and gave the company an “outperform” rating in a report on Tuesday. Royal Bank Of Canada lifted their price target on Chemours from $14.00 to $15.00 and gave the company an “outperform” rating in a report on Thursday, July 3rd. UBS Group decreased their target price on Chemours from $18.00 to $17.00 and set a “buy” rating for the company in a report on Wednesday, May 7th. Finally, Barclays reduced their price target on Chemours from $16.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 28th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $17.44.

Check Out Our Latest Stock Report on CC

Insider Buying and Selling at Chemours

In related news, insider Damian Gumpel purchased 7,822 shares of Chemours stock in a transaction dated Tuesday, June 3rd. The stock was acquired at an average cost of $9.95 per share, with a total value of $77,828.90. Following the completion of the transaction, the insider directly owned 131,701 shares of the company’s stock, valued at $1,310,424.95. This trade represents a 6.31% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shane Hostetter acquired 4,450 shares of Chemours stock in a transaction that occurred on Monday, May 19th. The shares were purchased at an average cost of $11.28 per share, with a total value of $50,196.00. Following the transaction, the chief financial officer owned 59,694 shares of the company’s stock, valued at approximately $673,348.32. The trade was a 8.06% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 25,672 shares of company stock valued at $251,573. 0.47% of the stock is currently owned by company insiders.

About Chemours

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.